TSE:4503 Overview
Upcoming Projects (TSE:4503)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (TSE:4503)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (TSE:4503)
-
Phase 2 Study Results of CK-2127107 on Patients with Spinal Muscular Atrophy Expected mid-2017
Tickers: CYTK, TSE:4503
Occurred on: Jul 05, 2017 -
Additional Phase 2 Study of CK-2127107 in Patients with COPD Set to Initiate 1H of 2016
Tickers: CYTK, TSE:4503
Occurred on: Jun 30, 2016 -
Phase 2 TERRAIN Trial of enzalutamide Compared to bicalutamide in Metastatic Castration-Resistant Prostate Cancer achieved its primary endpoint
Tickers: MDVN, TSE:4503, ALPMY
Occurred on: Jan 13, 2016
Strategic Initiatives (TSE:4503)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
